Opinion
Moderna Inc.’s highly effective COVID-19 vaccine, in addition to protecting millions, is officially a cash cow.The company disclosed during its earnings presentation Aug. 5 that it expects the shot to generate $20 billion in sales this year. Now it has to figure out what to do with its windfal...
Research and manufacturing delays have dogged the arrival of a COVID-19 vaccine from Novavax Inc., one of only six selected by the U.S. government’s Operation Warp Speed for a large order. At one point in May, the company’s shares were down 62% from a February high.On Monday, though, Nov...
Vaccines are a huge help in the Covid fight, paving the way for reopenings in towns, cities and countries around the world. But when it comes to cross-border commerce and travel, we need more than shots to get back to some kind of normal. Nowhere is that more evident than in the European Union, wher...
There are more than 10 effective Covid-19 vaccines in use around the world, so it's easy to forget those still in development. That's a mistake. These candidates may be taking longer to arrive, but they're essential to the pandemic fight. Most of the world is still unvaccinated, kee...
The world now seems likely to have at least two effective vaccines against Covid-19 with recent announcement of positive early data from Moderna Therapeutics Inc.’s 30,000-person clinical trial. The result comes a week after Pfizer Inc. and BioNTech SE revealed a protection rate of more than 9...
Last week I wrote that based on clinical trial math, the earliest looks at coronavirus vaccine data were less likely to succeed. I've never been happier to be wrong. Pfizer Inc. and BioNTech SE announced Monday that their vaccine candidate prevented over 90% of Covid-19 cases in an early look at...
Page 1 of 1, showing 6 results out of 6 total
